MENU
+Compare
VYGR
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$4.24
Change
+$0.36 (+9.28%)
Capitalization
235.19M

VYGR Voyager Therapeutics Forecast, Technical & Fundamental Analysis

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more

Industry: #Biotechnology
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VYGR with price predictions
Sep 05, 2025

VYGR in upward trend: price rose above 50-day moving average on August 12, 2025

VYGR moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on VYGR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VYGR just turned positive on September 03, 2025. Looking at past instances where VYGR's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where VYGR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VYGR broke above its upper Bollinger Band on September 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.963) is normal, around the industry mean (20.107). P/E Ratio (6.000) is within average values for comparable stocks, (52.767). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.138). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (5.797) is also within normal values, averaging (327.388).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VYGR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VYGR is expected to report earnings to fall 8.63% to -52 cents per share on November 18

Voyager Therapeutics VYGR Stock Earnings Reports
Q3'25
Est.
$-0.52
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.08
Q4'24
Missed
by $0.22
Q3'24
Beat
by $0.29
The last earnings report on August 06 showed earnings per share of -56 cents, missing the estimate of -52 cents. With 1.37M shares outstanding, the current market capitalization sits at 235.19M.
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMZPY5.610.57
+11.20%
Domino's Pizza Australia New Zealand
KMTUY34.730.62
+1.82%
Komatsu Ltd.
BZQIF1.90N/A
N/A
Bezeq The Israel Telecommunication Corp Ltd.
ETER0.05N/A
N/A
Enterra Corporation
UWHR9.98-0.08
-0.75%
Uwharrie Capital Corp

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+9.28%
RGNX - VYGR
52%
Loosely correlated
+3.08%
KYMR - VYGR
50%
Loosely correlated
+3.10%
XNCR - VYGR
49%
Loosely correlated
+2.15%
XENE - VYGR
47%
Loosely correlated
+1.48%
IMNM - VYGR
46%
Loosely correlated
+7.35%
More

Groups containing VYGR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+9.28%
gene therapy
theme (11 stocks)
51%
Loosely correlated
+3.72%
central nervous system
theme (3 stocks)
45%
Loosely correlated
+3.20%
biotechnology
theme (219 stocks)
43%
Loosely correlated
+1.87%
drugs
theme (234 stocks)
40%
Loosely correlated
+1.62%
surgery
theme (21 stocks)
27%
Poorly correlated
+1.77%
More